Related Experiment Videos
[Peripheral airway obstruction and treatment]
1First Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Nihon Kyobu Shikkan Gakkai Zasshi
|September 1, 1992
Summary
Medications like procaterol and ipratropium can prevent exercise- or hyperventilation-induced asthma. However, chronic peripheral airway obstruction in asthma remains challenging to treat effectively.
Area of Science:
- Respiratory Medicine
- Pharmacology
Context:
- Peripheral airway obstruction is a key feature of bronchial asthma.
- Understanding medication efficacy in different asthma phenotypes is crucial for treatment.
Purpose:
- To evaluate the effectiveness of various medications in preventing and treating peripheral airway obstruction in different asthma models.
- To compare the impact of procaterol, cromoglycate, and ipratropium on induced and chronic airway obstruction.
Summary:
- Procaterol and ipratropium effectively prevented exercise- or hyperventilation-induced peripheral airway obstruction in patients and an animal model.
- Cromoglycate showed partial effectiveness in prevention and was less effective in chronic asthma.
- Beclomethasone improved symptoms in chronic asthma but did not alter pulmonary function or airway responsiveness; subsequent cromoglycate treatment showed transient benefits.
Impact:
- Identifies specific medications for pre-emptive treatment of exercise- and hyperventilation-induced asthma.
- Highlights the limitations of current treatments for chronic peripheral airway obstruction in asthma.
- Informs clinical practice regarding medication selection for asthma management.